Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00691769 · ClinicalTrials.gov registry record
Expression of Fas Protein in Skin Biopsies of Participants With Scarring Alopecia
A clinical trial, sponsored by Wake Forest University.
- Completed
- Registry status
- 8
- Enrollment target
NCT00691769 is a clinical trial that has completed, run by Wake Forest University. The registered enrollment target is 8 participants.
The verdict
NCT00691769 has completed, sponsored by Wake Forest University.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
Study Summary
The purpose of this research study is to see if a specific protein that we are interested in is involved in scarring hair loss. If these proteins are involved, further genetic work may also better define the disease as well as future treatment options.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2006-04-26 |
| Est. Completion | 2012-11-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00691769
The ClinicalTrials.gov registry entry for NCT00691769 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University, which has 100 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00691769 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00691769 about?
NCT00691769 is a clinical study titled "Expression of Fas Protein in Skin Biopsies of Participants With Scarring Alopecia". The purpose of this research study is to see if a specific protein that we are interested in is involved in scarring hair loss. If these proteins are involved, further genetic work may also better define the disease as well as future treatment options.
What is the current status of trial NCT00691769?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2006-04-26. Estimated completion is 2012-11-26.
Who is sponsoring clinical trial NCT00691769?
This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.